AstraZeneca Other Vaccines & Immune Therapies by Quarter

Name: AstraZeneca Other Vaccines & Immune Therapies by Quarter (AZN)
Creator: AstraZeneca

Other Vaccines & Immune Therapies — Worldwide product sales ($M) ($M)

Quarterly Annual

AstraZeneca Other Vaccines & Immune Therapies: $34M in Q2 2026.

Latest, Q2 2026

Period ended Jun 30, 2026

Change on a year earlier

–

0 in Q2 2025

History

10 quarters

Since Q1 2024

Sources

Documents cited below

Where the Q2 2026 figure comes from

“|| Other ID | | 34 | | ( 31 ) | | ( 34 ) | | ( 1 ) | | 73 | | 30 | | ( 20 ) | | ( 26 ) | | 1 | | 78 | | 69 | | 4 | | ( 68 ) | | ( 66 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Other Vaccines & Immune Therapies — Worldwide product sales ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	34	–	Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026	Mar 31, 2026	58	+5,700.0%	Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025	Dec 31, 2025	1	-150.0%	Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025	Sep 30, 2025	0	–	Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025	Jun 30, 2025	0	–	Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025	Mar 31, 2025	1	-83.3%	Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024	Dec 31, 2024	-2	–	Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024	Sep 30, 2024	0	–	Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024	Jun 30, 2024	0	–	Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024	Mar 31, 2024	6	–	Form 6-K FY2024Q1 Earnings Release ↗

Breakdown

What makes up other Vaccines & Immune Therapies

Cite this data

StockData. (2026). AstraZeneca Other Vaccines & Immune Therapies ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-vi-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.